Our study here revealed a negative regulatory role of FOXP3 in tuning the self-renewal of cCSCs by inhibiting COX2 expression, which provides a new target and strategy for the removal of colon cancer stem cells. The gene discussed is FOXP3; the disease is malignant colon neoplasm.